The arrival of COVID-19 in Brazil and the impact on coronary artery bypass surgery

Omar A V Mejia1,2, Gabrielle B Borgomoni1, Lucas M V Silveira1

  • 1Department of Cardiovascular Surgery, Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina do Estado de São Paulo (InCor), São Paulo, São Paulo, Brazil.

Insights

The COVID-19 pandemic significantly increased mortality risk for coronary artery bypass grafting (CABG) surgeries in Brazil. Surgical volumes decreased by 60%, highlighting the pandemic's adverse impact on cardiovascular care.

Area of Science:

  • Cardiovascular Surgery
  • Infectious Diseases
  • Public Health

Background:

  • The emergence of coronavirus disease 2019 (COVID-19) presented unprecedented challenges to healthcare systems globally.
  • Brazil experienced a significant influx of COVID-19 cases, necessitating an analysis of its impact on specialized surgical procedures.

Purpose of the Study:

  • To analyze the impact of the COVID-19 pandemic on coronary artery bypass grafting (CABG) surgery in Brazil.
  • To compare outcomes and surgical volumes during the pre-COVID-19 period versus the COVID-19 era.

Main Methods:

  • A comparative study was conducted on isolated CABG patients across six Brazilian hospitals.
  • Data from March-May 2019 (pre-COVID-19) were compared with March-May 2020 (COVID-19 era).
  • Logistic regression was used to develop a predictive model for mortality in the COVID-19 era.

Main Results:

  • Coronary artery bypass grafting (CABG) surgery showed a 2.8-fold increase in mortality risk in 2020 compared to 2019.
  • Patients with COVID-19 experienced an 11-fold increased mortality risk after CABG.
  • Surgical volume decreased by 60%, with increased rates of morbidity and intensive care unit readmissions.

Conclusions:

  • The COVID-19 pandemic adversely affected mortality rates, morbidity, and the overall volume of CABG surgeries.
  • A validated predictive model for CABG mortality during the COVID-19 era demonstrated good calibration and discrimination.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
432
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
565
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
204
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
103
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
126
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
84